These emerging therapies, including Wegovy, Tirzepatide , and Retatrutide , represent a important advancement in managing type 2 diabetes and promoting weight management. They work by mimicking the body’s natural incretin GLP-1 , assisting to control blood levels and lower cravings. Each therapy has somewhat distinct qualities and can be suitable